FDA approved Dr. Reddy’s ANDA for Lansoprazole delayed-release capsules

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

Dr. Reddy’s Laboratories announced that it will be launching Lansoprazole delayed-release capsules (15 mg and 30 mg), a bioequivalent generic version of Prevacid®* Delayed-Release Capsules, in the US market. The Food & Drug Administration (FDA) approved Dr. Reddy’s ANDA for Lansoprazole delayed-release capsules on October 15, 2010. Launch preparations are complete and shipments will commence shortly. Dr. Reddy’s Lansoprazole delayed-release capsules are available in bottles of 30 & 90 counts in 15mg and 90 and 500 counts in 30 mg.

Driving Excellence in Pharmaceutical Production with Advanced Pharmaceutical Cooling Systems

AstraZeneca and Daiichi Report Datroway Efficacy for TNBC

Lonza Widens Cell and Gene Therapy Suite with New Products

No New Drug Submissions by the FDA With Shutdown in Place

How to Tell if Your Loved One is Developing an Addiction

Future-proof vial filling – How flexibility Along the Line Defines Success

How Smart Digital Strategies are Leading the Way in Pharmaceutical Manufacturing

Rethinking Real-World Data Partnerships: How to Fill Gaps Without Starting Over

Energy efficiency in pure steam generation: How small adjustments can lead…

Pharmacovigilance Systems Gaining Higher Ground with AI

ACHEMA 2027: Global Forum for Pharma and Life Sciences

SAE Media Group Unveils Brochure for AI in Drug Discovery 2026…

Amcor to showcase responsible and patient-centric packaging innovations at CPHI Frankfurt…

Kadans Science Partner secures one of the most significant deals in…

CPHI 2025: BENEO to present galenIQ™ as the granulation binder of…

FDA approved Dr. Reddy’s ANDA for Lansoprazole delayed-release capsules

Driving Excellence in Pharmaceutical Production with Advanced Pharmaceutical Cooling Systems

AstraZeneca and Daiichi Report Datroway Efficacy for TNBC

Lonza Widens Cell and Gene Therapy Suite with New Products

No New Drug Submissions by the FDA With Shutdown in Place

Driving Excellence in Pharmaceutical Production with...

Barrier Packaging Solutions for Biopharmaceuticals

Smart Labeling for Pharma Supply Chain...

Anti-Counterfeit Technologies in Pharma Packaging

AI-Powered Quality Control for Pharma Packaging

Patient-Centric Packaging Solutions in Pharma

Driving Excellence in Pharmaceutical Production with Advanced Pharmaceutical Cooling Systems

AstraZeneca and Daiichi Report Datroway Efficacy for TNBC

Lonza Widens Cell and Gene Therapy Suite with New Products

No New Drug Submissions by the FDA With Shutdown in Place

About us

latest updates

System

subscribe us

Resources

Subscribe

Driving Excellence in Pharmaceutical Production with Advanced Pharmaceutical Cooling Systems

Barrier Packaging Solutions for Biopharmaceuticals